PDS Biotechnology Corp (PDSB): Net Income
-$34.50M
Year ended 2025-12-31
-$33.67M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$34.50M | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$37.61M | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$42.94M | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$40.85M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$16.92M | n/m | 2023-03-28, From 2021-01-01 |
| 2020-12-31 | -$14.85M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$7.00M | n/m | 2021-03-18, From 2019-01-01 |
| 2018-12-31 | -$3.84M | n/m | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | -$50.86M | n/m | 2019-02-21, From 2017-01-01 |
| 2016-12-31 | -$38.82M | n/m | 2018-03-01, From 2016-01-01 |
| 2015-12-31 | -$28.08M | n/m | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | -$12.20M | n/m | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | -$6.88M | n/a | 2016-03-08, From 2013-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | 2025-12-31 | -$34.50M | n/m |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | -$26.48M | n/m |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | -$5.98M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | -$3.19M | n/m |
| Sol-Gel Technologies Ltd. (SLGL) | 2025-12-31 | -$6.13M | n/m |
| Veru Inc. (VERU) | 2025-09-30 | -$22.73M | n/m |
| Talphera, Inc. (TLPH) | 2025-12-31 | -$14.29M | n/m |
| Valion Bio, Inc. (VBIO) | 2025-12-31 | -$8.88M | n/m |
| Nuvectis Pharma, Inc. (NVCT) | 2025-12-31 | -$26.44M | n/m |
Compare PDSB, YARW, SBFM, CPHI side by side · Screen every company in Pharmaceutical Preparations ↗